Microbial Antigens Stimulate Metalloprotease-7 Secretion in Human B-Lymphocytes Using mTOR-Dependent and Independent Pathways

[1]  N. Kaminski,et al.  Validation of the prognostic value of MMP‐7 in idiopathic pulmonary fibrosis , 2017, Respirology.

[2]  İ. Reisli,et al.  CD19 controls Toll-like receptor 9 responses in human B cells. , 2016, The Journal of allergy and clinical immunology.

[3]  P. Malfertheiner,et al.  MMP2 and MMP7 at the invasive front of gastric cancer are not associated with mTOR expression , 2015, Diagnostic Pathology.

[4]  A. Limper,et al.  β-Glucan–Activated Human B Lymphocytes Participate in Innate Immune Responses by Releasing Proinflammatory Cytokines and Stimulating Neutrophil Chemotaxis , 2015, The Journal of Immunology.

[5]  M. Simons,et al.  Syndecan-4 signaling at a glance , 2013, Journal of Cell Science.

[6]  T. Colby,et al.  Blood biomarkers MMP-7 and SP-A: predictors of outcome in idiopathic pulmonary fibrosis. , 2013, Chest.

[7]  J. Couchman,et al.  Mapping of matrix metalloproteinase cleavage sites on syndecan‐1 and syndecan‐4 ectodomains , 2013, The FEBS journal.

[8]  M. Kilgore,et al.  Activation of the PKC Pathway Stimulates Ovarian Cancer Cell Proliferation, Migration, and Expression of MMP7 and MMP101 , 2012, Biology of reproduction.

[9]  R. Yeung,et al.  The loss of tuberin promotes cell invasion through the ß-catenin pathway. , 2010, American journal of respiratory cell and molecular biology.

[10]  J. McGrath,et al.  Matrix metalloproteinase‐7 activates heparin‐binding epidermal growth factor‐like growth factor in cutaneous squamous cell carcinoma , 2010, The British journal of dermatology.

[11]  J. Couchman,et al.  Proteoglycans in health and disease: the multiple roles of syndecan shedding , 2010, The FEBS journal.

[12]  R. Homer,et al.  Inhibition of pulmonary fibrosis in mice by CXCL10 requires glycosaminoglycan binding and syndecan-4. , 2010, The Journal of clinical investigation.

[13]  S. Nadler,et al.  MMP7 Shedding of Syndecan-1 Facilitates Re-Epithelialization by Affecting α2β1 Integrin Activation , 2009, PloS one.

[14]  U. Bommhardt,et al.  TLR9-Activating DNA Up-Regulates ZAP70 via Sustained PKB Induction in IgM+ B Cells1 , 2008, The Journal of Immunology.

[15]  B. Pulendran,et al.  Toll-like receptor–mediated induction of type I interferon in plasmacytoid dendritic cells requires the rapamycin-sensitive PI(3)K-mTOR-p70S6K pathway , 2008, Nature Immunology.

[16]  Naftali Kaminski,et al.  MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis , 2008, PLoS medicine.

[17]  D. Gray,et al.  Innate responses of B cells , 2007, European journal of immunology.

[18]  Allan B Dietz,et al.  A novel source of viable peripheral blood mononuclear cells from leukoreduction system chambers , 2006, Transfusion.

[19]  Séverine Brulé,et al.  The shedding of syndecan-4 and syndecan-1 from HeLa cells and human primary macrophages is accelerated by SDF-1/CXCL12 and mediated by the matrix metalloproteinase-9. , 2006, Glycobiology.

[20]  A. Woods,et al.  Syndecan-2 Is Expressed in the Microvasculature of Gliomas and Regulates Angiogenic Processes in Microvascular Endothelial Cells* , 2006, Journal of Biological Chemistry.

[21]  William C. Parks,et al.  Matrix metalloproteinases as modulators of inflammation and innate immunity , 2004, Nature Reviews Immunology.

[22]  T. Yoshizaki,et al.  Cleavage of Syndecan-1 by Membrane Type Matrix Metalloproteinase-1 Stimulates Cell Migration* , 2003, Journal of Biological Chemistry.

[23]  W. Parks,et al.  Matrilysin (matrix metalloproteinase-7) mediates E-cadherin ectodomain shedding in injured lung epithelium. , 2003, The American journal of pathology.

[24]  R. Visse,et al.  This Review Is Part of a Thematic Series on Matrix Metalloproteinases, Which Includes the following Articles: Matrix Metalloproteinase Inhibition after Myocardial Infarction: a New Approach to Prevent Heart Failure? Matrix Metalloproteinases in Vascular Remodeling and Atherogenesis: the Good, the Ba , 2022 .

[25]  William C. Parks,et al.  Matrilysin Shedding of Syndecan-1 Regulates Chemokine Mobilization and Transepithelial Efflux of Neutrophils in Acute Lung Injury , 2002, Cell.

[26]  E. Henske,et al.  Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Gunther Hartmann,et al.  Mechanism and Function of a Newly Identified CpG DNA Motif in Human Primary B Cells1 , 2000, The Journal of Immunology.

[28]  L. Matrisian,et al.  Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. , 1999, Science.

[29]  R. Wall,et al.  Syndecan-4 is expressed by B lineage lymphocytes and can transmit a signal for formation of dendritic processes. , 1999, Journal of immunology.

[30]  E. Henske,et al.  Evidence that lymphangiomyomatosis is caused by TSC2 mutations: chromosome 16p13 loss of heterozygosity in angiomyolipomas and lymph nodes from women with lymphangiomyomatosis. , 1998, American journal of human genetics.

[31]  A. Green,et al.  Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients , 1994, Nature Genetics.

[32]  D. Manners,et al.  The heterogeneity of glucan preparations from the walls of various yeasts. , 1974, Journal of general microbiology.

[33]  Patrick Nitschke,et al.  A human immunodeficiency caused by mutations in the PIK3R1 gene. , 2015, The Journal of clinical investigation.